Management of Neurological Complications

Jaeho Hwang; Bo Soo Kim; Ali Shabahang Saber Tehrani; Sung Min Cho

doi:10.1007/978-3-030-94992-1_11

Management of Neurological Complications

Jaeho Hwang, Bo Soo Kim, Ali Shabahang Saber Tehrani, Sung Min Cho

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Critically ill patients with COVID-19 pneumonia in the intensive care unit (ICU) may develop neurological complications of their central nervous system (CNS) or peripheral nervous system (PNS) that may arise directly from the COVID-19 virus, indirectly as a complication of the COVID-19-related hospitalization, or by mechanisms that have not yet been elucidated. These include encephalopathy, delirium, ischemic stroke, intracranial hemorrhage, peripheral nerve injury, and critical illness myopathy. As the evidence of neurological complications in COVID-19 patients accumulate, we aim to provide a concise review on optimal management strategies of these complications. For the purpose of our review, we are excluding patients in the ICU who develop new neurological symptoms and are found to have otherwise asymptomatic SARS-CoV-2 PCR positivity.

Original language	English (US)
Title of host publication	COVID-19 Critical and Intensive Care Medicine Essentials
Publisher	Springer International Publishing
Pages	127-136
Number of pages	10
ISBN (Electronic)	9783030949921
ISBN (Print)	9783030949914
DOIs	https://doi.org/10.1007/978-3-030-94992-1_11
State	Published - Jan 1 2022

ASJC Scopus subject areas

General Medicine
General Immunology and Microbiology

Access to Document

10.1007/978-3-030-94992-1_11

Cite this

@inbook{24ce215b498844b1ae835279c27ba924,

title = "Management of Neurological Complications",

abstract = "Critically ill patients with COVID-19 pneumonia in the intensive care unit (ICU) may develop neurological complications of their central nervous system (CNS) or peripheral nervous system (PNS) that may arise directly from the COVID-19 virus, indirectly as a complication of the COVID-19-related hospitalization, or by mechanisms that have not yet been elucidated. These include encephalopathy, delirium, ischemic stroke, intracranial hemorrhage, peripheral nerve injury, and critical illness myopathy. As the evidence of neurological complications in COVID-19 patients accumulate, we aim to provide a concise review on optimal management strategies of these complications. For the purpose of our review, we are excluding patients in the ICU who develop new neurological symptoms and are found to have otherwise asymptomatic SARS-CoV-2 PCR positivity.",

author = "Jaeho Hwang and Kim, {Bo Soo} and Tehrani, {Ali Shabahang Saber} and Cho, {Sung Min}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-030-94992-1_11",

language = "English (US)",

isbn = "9783030949914",

pages = "127--136",

booktitle = "COVID-19 Critical and Intensive Care Medicine Essentials",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Management of Neurological Complications

AU - Hwang, Jaeho

AU - Kim, Bo Soo

AU - Tehrani, Ali Shabahang Saber

AU - Cho, Sung Min

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Critically ill patients with COVID-19 pneumonia in the intensive care unit (ICU) may develop neurological complications of their central nervous system (CNS) or peripheral nervous system (PNS) that may arise directly from the COVID-19 virus, indirectly as a complication of the COVID-19-related hospitalization, or by mechanisms that have not yet been elucidated. These include encephalopathy, delirium, ischemic stroke, intracranial hemorrhage, peripheral nerve injury, and critical illness myopathy. As the evidence of neurological complications in COVID-19 patients accumulate, we aim to provide a concise review on optimal management strategies of these complications. For the purpose of our review, we are excluding patients in the ICU who develop new neurological symptoms and are found to have otherwise asymptomatic SARS-CoV-2 PCR positivity.

AB - Critically ill patients with COVID-19 pneumonia in the intensive care unit (ICU) may develop neurological complications of their central nervous system (CNS) or peripheral nervous system (PNS) that may arise directly from the COVID-19 virus, indirectly as a complication of the COVID-19-related hospitalization, or by mechanisms that have not yet been elucidated. These include encephalopathy, delirium, ischemic stroke, intracranial hemorrhage, peripheral nerve injury, and critical illness myopathy. As the evidence of neurological complications in COVID-19 patients accumulate, we aim to provide a concise review on optimal management strategies of these complications. For the purpose of our review, we are excluding patients in the ICU who develop new neurological symptoms and are found to have otherwise asymptomatic SARS-CoV-2 PCR positivity.

UR - http://www.scopus.com/inward/record.url?scp=85159029189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159029189&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-94992-1_11

DO - 10.1007/978-3-030-94992-1_11

M3 - Chapter

AN - SCOPUS:85159029189

SN - 9783030949914

SP - 127

EP - 136

BT - COVID-19 Critical and Intensive Care Medicine Essentials

PB - Springer International Publishing

ER -

Management of Neurological Complications

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this